Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-Life Experience of the Prognostic Significance of the Primary Tumor Location on the Timing of Colorectal Liver Metastases: A Retrospective Analysis.
Signorelli C, Amodio PM, Chilelli MG, Santoro R, Schirripa M, Ranalli TV, Pessina G, Giron Berrios JR, Natoni F, Virtuoso A, Primi F, Mazzotta M, Nelli F, Fabbri A, Marrucci E, Ruggeri EM. Signorelli C, et al. Among authors: nelli f. Cureus. 2022 Oct 23;14(10):e30607. doi: 10.7759/cureus.30607. eCollection 2022 Oct. Cureus. 2022. PMID: 36299600 Free PMC article.
Induction cisplatin-gemcitabine-paclitaxel plus concurrent radiotherapy and gemcitabine in the multimodality treatment of unresectable stage IIIB non-small cell lung cancer.
Trodella L, De Marinis F, D'Angelillo RM, Ramella S, Cesario A, Valente S, Nelli F, Migliorino MR, Margaritora S, Corbo GM, Porziella V, Ciresa M, Cellini F, Bonassi S, Russo P, Cortesi E, Granone P. Trodella L, et al. Among authors: nelli f. Lung Cancer. 2006 Dec;54(3):331-8. doi: 10.1016/j.lungcan.2006.07.020. Epub 2006 Sep 29. Lung Cancer. 2006. PMID: 17011065 Clinical Trial.
Induction therapy with paclitaxel and carboplatin followed by hyperfractionated radiotherapy plus weekly concurrent chemotherapy and subsequent consolidation therapy in unresectable locally advanced non-small-cell lung cancer.
Cortesi E, Moscetti L, Nelli F, De Marinis F, De Paula U, Bangrazi C, Migliorino MR, Donato V. Cortesi E, et al. Among authors: nelli f. Tumori. 2007 Mar-Apr;93(2):133-7. doi: 10.1177/030089160709300204. Tumori. 2007. PMID: 17557558 Clinical Trial.
Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial.
Garassino MC, Martelli O, Broggini M, Farina G, Veronese S, Rulli E, Bianchi F, Bettini A, Longo F, Moscetti L, Tomirotti M, Marabese M, Ganzinelli M, Lauricella C, Labianca R, Floriani I, Giaccone G, Torri V, Scanni A, Marsoni S; TAILOR trialists. Garassino MC, et al. Lancet Oncol. 2013 Sep;14(10):981-8. doi: 10.1016/S1470-2045(13)70310-3. Epub 2013 Jul 22. Lancet Oncol. 2013. PMID: 23883922 Clinical Trial.
79 results